Log in
Enquire now
‌

US Patent 10307371 Rapamycin for the treatment of lymphangioleiomyomatosis

Patent 10307371 was granted and assigned to AI Therapeutics on June, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Currently, there are no issues on this topic.

Find more entities like US Patent 10307371 Rapamycin for the treatment of lymphangioleiomyomatosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.